Ergoloid

Ergoloid
Combination of
Dihydroergocristine	Ergot alkaloid
Dihydroergocornine	Ergot alkaloid
alpha-Dihydroergocryptine	Ergot alkaloid
beta-Dihydroergocryptine	Ergot alkaloid
Clinical data
Other names	Co-dergocrine, dihydroergotoxine
Pregnancy; category	Contraindicated;
Routes of; administration	Oral, parenteral
ATC code	C04AE01 (WHO) ;
Legal status
Legal status	In general: ℞ (Prescription only);
Pharmacokinetic data
Bioavailability	25%
Protein binding	98–99%
Metabolism	50%
Elimination half-life	3.5 hours
Identifiers
CAS Number	8067-24-1 ;
DrugBank	DB01049 ;
ChemSpider	none;
UNII	X3S33EX3KW;
ChEBI	CHEBI:59756 ;
CompTox Dashboard (EPA)	DTXSID5031428 ;
ECHA InfoCard	100.158.718
	(what is this?) (verify)

Ergoloid mesylates (USAN), co-dergocrine mesilate (BAN) or dihydroergotoxine mesylate, trade name Hydergine, is a mixture of the methanesulfonate salts of three dihydrogenated ergot alkaloids (dihydroergocristine, dihydroergocornine, and alpha- and beta-dihydroergocryptine).

It was developed by Albert Hofmann (the discoverer of LSD) for Sandoz (now part of Novartis).